{"transactions":[{"id":779464,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-14T20:56:57.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":10958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy, and was not sold to the Reporting Person. As such, the Reporting person did not pay any consideration for the derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest on the earlier of the one-year anniversary of the date of grant and the date of Issuer's next Annual Meeting following the date of grant, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":10958,"derivative":{"exercise_price":24.63,"expiration_date":"2036-05-11","underlying":"Common Stock","underlying_shares":10958},"source":{"system":"sec-edgar","filing":"0001670893-26-000002","document":"wk-form4_1778792215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999480/000167089326000002/wk-form4_1778792215.xml","form_type":"4"}},{"id":1113326,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-12T20:26:22.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Since the date of the reporting person's last ownership report, the individual transferred 4,917 shares of Class A common stock to the individual's ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the individual's ex-spouse."}],"balance_after":228313,"source":{"system":"sec-edgar","filing":"0000950170-25-085437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000095017025085437/ownership.xml","form_type":"4"}},{"id":1147712,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-15T20:16:28.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":15287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The derivative securities were granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest on the earlier of the one-year anniversary of the date of grant and the date of Issuer's next Annual Meeting following the date of grant, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":15287,"derivative":{"exercise_price":2.37,"expiration_date":"2035-05-12","underlying":"Common Stock","underlying_shares":15287},"source":{"system":"sec-edgar","filing":"0001999480-25-000039","document":"wk-form4_1747340182.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999480/000199948025000039/wk-form4_1747340182.xml","form_type":"4"}},{"id":1472047,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-21T20:05:11.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":24311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Since the date of the reporting person's last ownership report, the individual transferred 5,061 shares of Class A common stock to the individual's ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the individual's ex-spouse."}],"balance_after":188230,"source":{"system":"sec-edgar","filing":"0000950170-24-076211","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000095017024076211/ownership.xml","form_type":"4"}},{"id":1659380,"issuer":{"id":4755,"kind":"organization","name":"Alto Neuroscience, Inc.","symbol":"ANRO"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-05T21:40:49.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":30574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest in 36 equal monthly installments commencing on March 1, 2024, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":30574,"derivative":{"exercise_price":16,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":30574},"source":{"system":"sec-edgar","filing":"0001415889-24-002553","document":"form4-02052024_090236.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1999480/000141588924002553/form4-02052024_090236.xml","form_type":"4"}},{"id":1846537,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-22T21:27:49.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":22350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Since the date of the reporting person's last ownership report, the individual transferred 5,009 shares of Class A common stock to the individual's ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the individual's ex-spouse."}],"balance_after":168980,"source":{"system":"sec-edgar","filing":"0001209191-23-039134","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919123039134/doc4.xml","form_type":"4"}},{"id":2244749,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-06-03T20:05:30.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":21571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total amount of shares beneficially owned has been adjusted to correct prior immaterial computational errors."}],"balance_after":151639,"source":{"system":"sec-edgar","filing":"0001209191-22-033965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919122033965/doc4.xml","form_type":"4"}},{"id":2466137,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-17T21:05:27.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":1431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Policy, effective as of May 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Since the date of the reporting person's last ownership report, the individual transferred 6,014 shares of Class A common stock to the individual's ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the individual's ex-spouse."}],"balance_after":130077,"source":{"system":"sec-edgar","filing":"0001209191-21-070234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919121070234/doc4.xml","form_type":"4"}},{"id":2565805,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-09-17T20:47:13.000Z","date":"2021-09-15","kind":"grant","acquired":true,"shares":1344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Policy, effective May 2019."}],"balance_after":134660,"source":{"system":"sec-edgar","filing":"0001209191-21-056656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919121056656/doc4.xml","form_type":"4"}},{"id":2666338,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-16T20:31:54.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":1453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Policy, effective May 2019."}],"balance_after":133316,"source":{"system":"sec-edgar","filing":"0001209191-21-040921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919121040921/doc4.xml","form_type":"4"}},{"id":2680958,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-04T20:07:12.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":22766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":131863,"source":{"system":"sec-edgar","filing":"0001209191-21-038191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919121038191/doc4.xml","form_type":"4"}},{"id":2782517,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-03-17T20:03:53.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":1460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Policy, effective May 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Since the date of the reporting person's last ownership report, the individual transferred 5,723 shares of Class A common stock to the individual's ex-spouse pursuant to a domestic relations order.  The reporting person no longer reports as beneficially owned any securities owned by the individual's ex-spouse."}],"balance_after":109097,"source":{"system":"sec-edgar","filing":"0001209191-21-021299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919121021299/doc4.xml","form_type":"4"}},{"id":4613165,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-12-17T21:12:31.000Z","date":"2020-12-15","kind":"grant","acquired":true,"shares":1357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Policy, effective May 2019."}],"balance_after":113360,"source":{"system":"sec-edgar","filing":"0001209191-20-064043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919120064043/doc4.xml","form_type":"4"}},{"id":3028548,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-09-17T20:12:51.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Policy, effective May 2019."}],"balance_after":112003,"source":{"system":"sec-edgar","filing":"0001209191-20-050875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919120050875/doc4.xml","form_type":"4"}},{"id":3109076,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-06-16T21:49:02.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":1745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Policy, effective May 2019."}],"balance_after":110403,"source":{"system":"sec-edgar","filing":"0001209191-20-037035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919120037035/doc4.xml","form_type":"4"}},{"id":3120505,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-06-05T20:32:41.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":21720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":108658,"source":{"system":"sec-edgar","filing":"0001209191-20-034693","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919120034693/doc4.xml","form_type":"4"}},{"id":3205405,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-03-17T20:04:20.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":1596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Policy, effective May 2019."}],"balance_after":86938,"source":{"system":"sec-edgar","filing":"0001209191-20-019543","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919120019543/doc4.xml","form_type":"4"}},{"id":3339029,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-12-17T21:02:26.000Z","date":"2019-12-13","kind":"grant","acquired":true,"shares":1270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Policy, effective May 2019."}],"balance_after":85342,"source":{"system":"sec-edgar","filing":"0001209191-19-060843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919119060843/doc4.xml","form_type":"4"}},{"id":3413912,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-09-16T20:53:31.000Z","date":"2019-09-13","kind":"grant","acquired":true,"shares":1692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Policy, effective as of May 2019."}],"balance_after":84072,"source":{"system":"sec-edgar","filing":"0001209191-19-049666","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919119049666/doc4.xml","form_type":"4"}},{"id":3486224,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-06-18T20:16:10.000Z","date":"2019-06-14","kind":"grant","acquired":true,"shares":1567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the director compensation policy."}],"balance_after":82380,"source":{"system":"sec-edgar","filing":"0001209191-19-037676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919119037676/doc4.xml","form_type":"4"}},{"id":3506414,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-05-31T20:05:46.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":22706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the director compensation policy, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":80813,"source":{"system":"sec-edgar","filing":"0001209191-19-033621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919119033621/doc4.xml","form_type":"4"}},{"id":3908527,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2018-06-04T21:27:17.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":16223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Plan, effective as of January 2014."}],"balance_after":58107,"source":{"system":"sec-edgar","filing":"0001209191-18-035245","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919118035245/doc4.xml","form_type":"4"}},{"id":4295873,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":47389,"kind":"person","name":"Dreyfus Andrew","position":1,"cik":"0001670893","reported_name":"Dreyfus Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2017-06-02T20:57:55.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Plan, effective as of January 2014."}],"balance_after":41884,"source":{"system":"sec-edgar","filing":"0001209191-17-037350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670893/000120919117037350/doc4.xml","form_type":"4"}}]}